SPARC's Stock Performance Continues to Impress in Pharmaceutical Industry

Oct 30 2024 10:50 AM IST
share
Share Via
SPARC, a midcap pharmaceutical company, has been gaining attention in the industry with its recent stock performance. On October 30, 2024, the stock saw a 5.14% increase, outperforming the sector by 5.93%. This trend has continued for the last three days, with a consecutive gain of 7.74%. While MarketsMojo rates the stock as 'Strong Sell', it has been performing well in the market, with an intraday high of Rs 223.85 (6.01%). The stock is currently above its short-term moving averages, indicating a positive trend, but may face resistance in the future. In comparison to the overall market, SPARC has outperformed the Sensex by 4.19% in the last day and 1.85% in the last month. With its recent performance and positive outlook, SPARC is a company to watch in the pharmaceutical industry.

Sun Pharma Advanced Research Company (SPARC) has been making headlines in the pharmaceutical industry with its recent stock performance. On October 30, 2024, the company's stock gained 5.14%, outperforming the sector by 5.93%. This positive trend has been consistent for the last three days, with a consecutive gain of 7.74% during this period.

According to MarketsMOJO, a leading stock market analysis platform, the stock call for SPARC is currently 'Strong Sell'. However, the company's stock has been performing well in the market, with an intraday high of Rs 223.85 (6.01%). This indicates a strong upward trend for the company's stock.

In terms of moving averages, SPARC's stock is currently higher than its 5-day, 20-day, and 50-day moving averages. However, it is lower than its 100-day and 200-day moving averages. This suggests that the stock has been on an upward trend, but it may face some resistance in the near future.

In comparison to the overall market performance, SPARC has outperformed the Sensex by 4.19% in the last 1 day and 1.85% in the last 1 month. This indicates that the company's stock is performing well, despite the market's negative trend.

SPARC is a midcap company in the pharmaceutical and drugs industry. With its recent stock performance and positive outlook, it is definitely a company to keep an eye on in the market. However, it is important to note that this article is based on factual information and does not include any external data or sources. As always, it is recommended to do your own research and consult with a financial advisor before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News